IL289438A - System and method for removal of immune inhibitors from biological fluids - Google Patents
System and method for removal of immune inhibitors from biological fluidsInfo
- Publication number
- IL289438A IL289438A IL289438A IL28943821A IL289438A IL 289438 A IL289438 A IL 289438A IL 289438 A IL289438 A IL 289438A IL 28943821 A IL28943821 A IL 28943821A IL 289438 A IL289438 A IL 289438A
- Authority
- IL
- Israel
- Prior art keywords
- removal
- biological fluids
- immune inhibitors
- immune
- inhibitors
- Prior art date
Links
- 239000013060 biological fluid Substances 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
- A61M1/3486—Biological, chemical treatment, e.g. chemical precipitation; treatment by absorbents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/362—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits changing physical properties of target cells by binding them to added particles to facilitate their subsequent separation from other cells, e.g. immunoaffinity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3687—Chemical treatment
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/525—Tumour necrosis factor [TNF]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/04—Liquids
- A61M2202/0413—Blood
- A61M2202/0415—Plasma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/75—General characteristics of the apparatus with filters
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Anesthesiology (AREA)
- Cell Biology (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Biodiversity & Conservation Biology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- General Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2019/062177 WO2021101519A1 (en) | 2019-11-19 | 2019-11-19 | System and method for removal of immune inhibitors from biological fluids |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| IL289438A true IL289438A (en) | 2022-02-01 |
| IL289438B1 IL289438B1 (en) | 2023-05-01 |
| IL289438B2 IL289438B2 (en) | 2023-09-01 |
Family
ID=75980821
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL289438A IL289438B2 (en) | 2019-11-19 | 2019-11-19 | System and method for removal of immune inhibitors from biological fluids |
| IL301912A IL301912A (en) | 2019-11-19 | 2019-11-19 | System and method for removal of immune inhibitors from biological fluids |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL301912A IL301912A (en) | 2019-11-19 | 2019-11-19 | System and method for removal of immune inhibitors from biological fluids |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP3846875A4 (en) |
| JP (2) | JP7159493B2 (en) |
| KR (2) | KR102491518B1 (en) |
| CN (1) | CN114650852B (en) |
| AU (3) | AU2019474912B2 (en) |
| CA (2) | CA3153685C (en) |
| IL (2) | IL289438B2 (en) |
| WO (1) | WO2021101519A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116648272A (en) * | 2020-10-01 | 2023-08-25 | 英谬免疫股份有限公司 | Reducing ligand leakage |
| US11224858B1 (en) | 2020-10-01 | 2022-01-18 | Immunicom, Inc. | Reduced leaching of a ligand |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996025228A1 (en) * | 1995-02-16 | 1996-08-22 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | ADSORBENT FOR TUMOR NECROSIS FACTOR α, METHOD OF REMOVAL BY ADSORPTION, AND ADSORPTION DEVICE USING SAID ADSORBENT |
| US8197430B1 (en) * | 1998-05-22 | 2012-06-12 | Biopheresis Technologies, Inc. | Method and system to remove cytokine inhibitor in patients |
| JP4150838B2 (en) | 1999-11-02 | 2008-09-17 | 株式会社カネカ | Filter for preventing packing outflow and adsorber equipped with the filter |
| EP1624785B1 (en) * | 2003-01-17 | 2013-07-17 | Aethlon Medical, Inc. | Method for removal of viruses from blood by lectin affinity hemodialysis |
| JP2006288571A (en) | 2005-04-08 | 2006-10-26 | Toray Ind Inc | Adsorbent for cancer treatment and column for extracorporeal circulation |
| JP4925159B2 (en) * | 2005-10-12 | 2012-04-25 | 日機装株式会社 | Blood purification equipment |
| KR20120093397A (en) * | 2007-08-31 | 2012-08-22 | 이노베이티브 바이오테라피스, 인크. | Selective cytopheresis devices and related methods thereof |
| JP2009178523A (en) * | 2008-02-01 | 2009-08-13 | Kaneka Corp | Adsorbent, adsorbing method and adsorbing device for soluble tumor necrosis factor receptor |
| JP5341559B2 (en) | 2009-03-03 | 2013-11-13 | 和雄 寺本 | Porous adsorbent |
| US9717841B2 (en) * | 2012-09-11 | 2017-08-01 | Gary L. McNeil | Closed-circuit device and methods for isolation, modification, and re-administration of specific constituents from a biological fluid source |
| US9227005B2 (en) * | 2013-03-14 | 2016-01-05 | Brian J LeBerthon | Method and device for treating cancer |
| US20170014450A1 (en) | 2014-02-28 | 2017-01-19 | Exosome Sciences, Inc. | Brain specific exosome based diagnostics and extracorporeal therapies |
| CN106457205B (en) * | 2014-07-22 | 2020-09-22 | 旭化成医疗株式会社 | Adsorption material for removing histone and biological source liquid purifying equipment |
| EP3274010B1 (en) | 2015-03-27 | 2019-10-02 | Eliaz Therapeutics, Inc. | Patient selective apheresis |
| HUE064189T2 (en) * | 2016-07-28 | 2024-02-28 | Captec Medical Kft | Flow capture device for removing cells from blood |
| US20190247560A1 (en) * | 2018-02-13 | 2019-08-15 | Gambro Lundia Ab | Extracorporeal devices and methods of treating complement factor related diseases |
| DE102018104177A1 (en) * | 2018-02-23 | 2019-08-29 | B. Braun Avitum Ag | Apparatus for removing noxious substances from blood, extracorporeal perfusion system comprising such a device and method for producing such a device |
| WO2019167048A1 (en) * | 2018-02-28 | 2019-09-06 | Plas-free Ltd. | Extracorporeal device and matrix for removing fibrinolytic proteins from biological fluids, methods and uses thereof |
-
2019
- 2019-11-19 IL IL289438A patent/IL289438B2/en unknown
- 2019-11-19 CN CN201980102088.9A patent/CN114650852B/en active Active
- 2019-11-19 JP JP2021572881A patent/JP7159493B2/en active Active
- 2019-11-19 WO PCT/US2019/062177 patent/WO2021101519A1/en unknown
- 2019-11-19 KR KR1020227003407A patent/KR102491518B1/en active IP Right Grant
- 2019-11-19 CA CA3153685A patent/CA3153685C/en active Active
- 2019-11-19 IL IL301912A patent/IL301912A/en unknown
- 2019-11-19 AU AU2019474912A patent/AU2019474912B2/en active Active
- 2019-11-19 CA CA3165330A patent/CA3165330A1/en active Pending
- 2019-11-19 EP EP19920634.3A patent/EP3846875A4/en active Pending
- 2019-11-19 KR KR1020237002011A patent/KR20230016032A/en not_active Application Discontinuation
-
2022
- 2022-05-16 AU AU2022203249A patent/AU2022203249B2/en active Active
- 2022-10-12 JP JP2022163897A patent/JP7514281B2/en active Active
-
2023
- 2023-11-29 AU AU2023274130A patent/AU2023274130A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2022203249B2 (en) | 2023-08-31 |
| KR20220039724A (en) | 2022-03-29 |
| EP3846875A1 (en) | 2021-07-14 |
| CN114650852A (en) | 2022-06-21 |
| WO2021101519A1 (en) | 2021-05-27 |
| CN114650852B (en) | 2024-08-06 |
| CA3153685C (en) | 2022-10-11 |
| KR20230016032A (en) | 2023-01-31 |
| AU2019474912B2 (en) | 2022-02-17 |
| EP3846875A4 (en) | 2021-07-14 |
| KR102491518B1 (en) | 2023-01-20 |
| IL301912A (en) | 2023-06-01 |
| AU2022203249A1 (en) | 2022-06-23 |
| CA3153685A1 (en) | 2021-05-27 |
| IL289438B2 (en) | 2023-09-01 |
| IL289438B1 (en) | 2023-05-01 |
| JP7514281B2 (en) | 2024-07-10 |
| AU2023274130A1 (en) | 2023-12-21 |
| CA3165330A1 (en) | 2021-05-27 |
| JP2023015053A (en) | 2023-01-31 |
| JP2022535604A (en) | 2022-08-09 |
| JP7159493B2 (en) | 2022-10-24 |
| AU2019474912A1 (en) | 2022-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11202004455UA (en) | System and method for executing different types of blockchain contracts | |
| GB201813459D0 (en) | Transaction system and method of operation thereof | |
| IL289438A (en) | System and method for removal of immune inhibitors from biological fluids | |
| IL267885B (en) | Methods and systems for computer-based determining of presence of objects | |
| EP3857860C0 (en) | System and method for disambiguation of internet-of-things devices | |
| GB2587911B (en) | System and method for implementing discriminated cybersecurity interventions | |
| SG11202106326PA (en) | System and method for modification of substrates | |
| EP3785746C0 (en) | System and method for irradiating biological fluids | |
| EP3948721A4 (en) | System and method of identifying equivalents for task completion | |
| EP3884221A4 (en) | Method and apparatus for freezing of biological products | |
| EP3731891C0 (en) | System and method for treatment of hemorrhagic fluid for autotransfusion | |
| SG11202008734WA (en) | Method and system of protein extraction | |
| EP4034952A4 (en) | Method and system for identification and analysis of regime shift | |
| GB202115550D0 (en) | System and method for management of substances | |
| EP3966167C0 (en) | Method for abatement of hydrocarbon and metals | |
| NO20180680A1 (en) | Subsea process system and method of operation | |
| IL287180A (en) | Method and system for classification of samples | |
| GB202019060D0 (en) | Liquid processing system and method of operation | |
| PL3770545T3 (en) | Device for and method of cleaning installations | |
| GB2575438B (en) | System and method for processing shellfish | |
| EP3621924A4 (en) | Method and apparatus for removal of surface scum | |
| GB2578012B (en) | System and method for fluid processing | |
| IL263724A (en) | System and method for treatment of wastewater fluids | |
| EP3990048C0 (en) | System and method for the treatment of haemorrhagic fluid for autotransfusion | |
| HK1256396A1 (en) | Method and system for flow limiting of servers |